InvestorsHub Logo
Post# of 89565
Next 10

sd3

Followers 0
Posts 205
Boards Moderated 0
Alias Born 03/21/2001

sd3

Member Level

Re: None

Wednesday, 08/01/2001 8:02:20 AM

Wednesday, August 01, 2001 8:02:20 AM

Post# of 89565
PNOS (PNSA) News

Ponte Nossa Post-Split Shares Assigned New Symbol Business Editors




IRVINE, Calif.--(BUSINESS WIRE)--Aug. 1, 2001--Ponte Nossa
Acquisition Corp. (OTCBB:PNSA) today announced that its stock symbol
will be modified to (OTCBB:PNSO) to reflect new post-split shares.
Shares resulting from the company's 26-1 split that became
effective July 26, 2001 will have the new symbol for clarification and
tracking.
Thomas DiMele, president of Ponte Nossa Acquisition Corp.,
indicated that the symbol reassignment was due to the type of split
transaction that occurred. "The shares are `payable upon surrender'
which means that the original stock is physically turned in and
replaced by the newly issued post-split shares," he explained.
Individual investors can turn in shares, although a brokerage house
generally completes the transaction.
In addition to the recent stock split, Ponte Nossa also just
successfully negotiated the acquisition of Visijet Inc., a privately
held ophthalmic medical device company located in Irvine.
Visijet, founded in 1996, is the developer of an exciting new
technology that uses a high pressure micro beam of water to perform
surgical cuts for ocular procedures -- similarly to how a laser uses
light to dissect tissue. The company's first product, approved by the
FDA in October 2000 is the Hydrokeratome(R), an innovative, patented
device that offers "bladeless" surgery to perform the cutting of the
cornea that is required in LASIK surgery.
LASIK surgery is a procedure growing in popularity that allows
individuals to have corrected visual acuity without glasses or contact
lenses. It is estimated that more than 3 million LASIK surgeries were
performed last year worldwide.
Visijet's second product, the Pulsatome(R), is a device that uses
the waterjet technology to remove cataracts -- the most performed
surgical procedure in the world. The Pulsatome(R) will provide entry
into an estimated $8 billion cataract market worldwide. FDA approval
for the device is anticipated in early 2002. In addition, Visijet has
several ophthalmic devices utilizing the waterjet technology under
development.
The new Ponte Nossa symbol is effective Aug. 1, 2001.

Forward-Looking Statement

Except for historical information contained herein, the matters
discussed in this news release are forward-looking statements within
the meaning of the Securities Exchange Act that involve risks and
uncertainties that could cause actual results to differ materially
from those expressed. These matters include, but are not limited to,
information about the company's technologies and products, financial
situations, or business opportunities. This news release shall not
constitute an offer to sell or the solicitation of an offer to sell
any of these securities.

--30--flb/np* jp/np

CONTACT: Mitchell & Co.
Diane Mitchell (public relations), 949/474-7020

KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: MEDICAL MEDICAL DEVICES
SOURCE: Ponte Nossa Acquisition Corp.

Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: http://www.businesswire.com





Aug-01-2001 12:00 GMT
Symbols:
US;PNSA US;PNSO
Source BW Business Wire
Categories:
MST/R/US/CA MST/I/MTC MST/I/MTC

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.